Autres langues Cytosorbents Corporation

Actions

CTSO

US23283X2062

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 28/08/2026			Varia. 5j.	Varia. 1 janv.
0,3356 ^USD	-1,41 %		-9,30 %	-47,50 %

06/08	Transcript : Cytosorbents Corporation, Q2 2026 Earnings Call, Aug 06, 2026
06/08	Cytosorbents Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

07/08	CytoSorbents : Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
07/08	Cytosorbents : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
06/08	CytoSorbents: Q2 Earnings Snapshot
06/08	Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
18/06	CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
14/05	Cytosorbents : Press Release (ctso q126 earnings press release 5 13 26 final one for distribution)
14/05	Cytosorbents : Presentation (ctso q1 2026 earnings presentation 5 13 26 final one final)
13/05	Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
13/05	CytoSorbents: Q1 Earnings Snapshot
13/05	CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
30/04	CytoSorbents : to Report First Quarter 2026 Financial Results and Recent Business Highlights
07/04	Cytosorbents : Investor Presentation (cytosorbents investor presentation april 2026 website)
25/03	CytoSorbents: Q4 Earnings Snapshot
25/03	Cytosorbents Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
19/03	CytoSorbents Corporation Announces Launch of HotSwap and Reports New Clinical Evidence
12/01	Cytosorbents : Investor Presentation (cytosorbents investor presentation january 2026 final)
12/01	Cytosorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
18/11	CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
15/11	Cytosorbents : Presentation (ctso 3q25 earnings presentation 11 13 25 final)
13/11	CytoSorbents: Q3 Earnings Snapshot
13/11	Blood purification firm CytoSorbents Q3 revenue misses estimates
13/11	Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Cytosorbents Corporation Reduces its Workforce by Approximately 10%
12/11	CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
31/10/25	CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights